Proceedings of 53rd AGM of the Company held on 23-Jun-26

Torrent Pharmaceuticals Ltd held its 53rd Annual General Meeting on June 23, 2026, where shareholders approved the Standalone and Consolidated Financial Statements for the fiscal year ended March 31, 2026. The meeting confirmed an interim dividend of ₹29.00 and declared a final dividend of ₹9.00 per equity share for FY26. Significantly, shareholders also approved the issuance of equity shares, including convertible bonds/debentures, providing the company with flexibility for future fundraising. Additionally, Samir Mehta was re-appointed as Director, and the remuneration of cost auditors for 2026-27 was ratified.